Conatus Pharmaceuticals Stock Price - CNAT

0.3101
0.00 (0.0%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Conatus Pharmaceuticals Inc CNAT NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.3101 0.00 0.00 0.00 0.3101 04:00:00
Bid Price Ask Price Spread Spread % News
0.25 0.365 0.115 31.51% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.3101 USD

Conatus Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 10.29M 33.17M $ -18.01M -0.34 -0.91 32.98M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Conatus Pharmaceuticals News

Date Time Source News Article
3/30/202017:03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in..
3/30/202016:18Edgar (US Regulatory)Current Report Filing (8-k)
3/13/202017:10Edgar (US Regulatory)Registration Statement for Securities to Be Issued in..
3/11/202017:02Edgar (US Regulatory)Annual Report (10-k)
3/11/202016:45Edgar (US Regulatory)Current Report Filing (8-k)
3/11/202016:45GlobeNewswire Inc.Conatus Pharmaceuticals Reports 2019 Financial Results and..
2/07/202017:09Edgar (US Regulatory)Securities Registration: Business Combination (s-4)

Latest CNAT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CNAT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.3050.340.290.3077425267,8150.00511.67%
1 Month0.430.440.23030.3188922346,813-0.1199-27.88%
3 Months0.400.57990.23030.4184396715,456-0.0899-22.48%
6 Months0.3260.57990.23030.3941898637,576-0.0159-4.88%
1 Year1.081.440.23030.4848238781,713-0.7699-71.29%
3 Years5.719.400.23033.03699,511-5.40-94.57%
5 Years6.989.400.23033.44642,613-6.67-95.56%

Conatus Pharmaceuticals Description

Conatus Pharmaceuticals Inc is a biotechnology company. It focuses on the development and commercialization of novel medicines to treat liver disease. The company is developing emricasan, an orally active pan-caspase protease inhibitor, for the treatment of patients with the chronic liver disease.
Your Recent History
NASDAQ
CNAT
Conatus Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200401 08:17:21